Search Results - "Rumi, E."

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms by Pietra, D, Rumi, E, Ferretti, V V, Buduo, C A Di, Milanesi, C, Cavalloni, C, Sant'Antonio, E, Abbonante, V, Moccia, F, Casetti, I C, Bellini, M, Renna, M C, Roncoroni, E, Fugazza, E, Astori, C, Boveri, E, Rosti, V, Barosi, G, Balduini, A, Cazzola, M

“…A quarter of patients with essential thrombocythemia or primary myelofibrosis carry a driver mutation of CALR , the calreticulin gene. A 52-bp deletion (type…”
Get full text

Mutations and prognosis in primary myelofibrosis by Vannucchi, A M, Lasho, T L, Guglielmelli, P, Biamonte, F, Pardanani, A, Pereira, A, Finke, C, Score, J, Gangat, N, Mannarelli, C, Ketterling, R P, Rotunno, G, Knudson, R A, Susini, M C, Laborde, R R, Spolverini, A, Pancrazzi, A, Pieri, L, Manfredini, R, Tagliafico, E, Zini, R, Jones, A, Zoi, K, Reiter, A, Duncombe, A, Pietra, D, Rumi, E, Cervantes, F, Barosi, G, Cazzola, M, Cross, N C P, Tefferi, A

“…Patient outcome in primary myelofibrosis (PMF) is significantly influenced by karyotype. We studied 879 PMF patients to determine the individual and…”
Get full text

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients by Guglielmelli, P, Lasho, T L, Rotunno, G, Score, J, Mannarelli, C, Pancrazzi, A, Biamonte, F, Pardanani, A, Zoi, K, Reiter, A, Duncombe, A, Fanelli, T, Pietra, D, Rumi, E, Finke, C, Gangat, N, Ketterling, R P, Knudson, R A, Hanson, C A, Bosi, A, Pereira, A, Manfredini, R, Cervantes, F, Barosi, G, Cazzola, M, Cross, N C P, Vannucchi, A M, Tefferi, A

“…We recently defined a high-molecular risk category (HMR) in primary myelofibrosis (PMF), based on the presence of at least one of the five ‘prognostically…”
Get full text

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis by Passamonti, F, Giorgino, T, Mora, B, Guglielmelli, P, Rumi, E, Maffioli, M, Rambaldi, A, Caramella, M, Komrokji, R, Gotlib, J, Kiladjian, J J, Cervantes, F, Devos, T, Palandri, F, De Stefano, V, Ruggeri, M, Silver, R T, Benevolo, G, Albano, F, Caramazza, D, Merli, M, Pietra, D, Casalone, R, Rotunno, G, Barbui, T, Cazzola, M, Vannucchi, A M

“…Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms with variable risk of evolution into post-PV and post-ET…”
Get full text

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study by Tefferi, A, Rumi, E, Finazzi, G, Gisslinger, H, Vannucchi, A M, Rodeghiero, F, Randi, M L, Vaidya, R, Cazzola, M, Rambaldi, A, Gisslinger, B, Pieri, L, Ruggeri, M, Bertozzi, I, Sulai, N H, Casetti, I, Carobbio, A, Jeryczynski, G, Larson, D R, Müllauer, L, Pardanani, A, Thiele, J, Passamonti, F, Barbui, T

“…Under the auspices of an International Working Group, seven centers submitted diagnostic and follow-up information on 1545 patients with World Health…”
Get full text

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications by Passamonti, F, Rumi, E, Pietra, D, Elena, C, Boveri, E, Arcaini, L, Roncoroni, E, Astori, C, Merli, M, Boggi, S, Pascutto, C, Lazzarino, M, Cazzola, M

“…We studied the relationship between JAK2 (V617F) mutant allele burden and clinical phenotype, disease progression and survival in patients with polycythemia…”
Get full text

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia by Barbui, T, Vannucchi, A M, Buxhofer-Ausch, V, De Stefano, V, Betti, S, Rambaldi, A, Rumi, E, Ruggeri, M, Rodeghiero, F, Randi, M L, Bertozzi, I, Gisslinger, H, Finazzi, G, Carobbio, A, Thiele, J, Passamonti, F, Falcone, C, Tefferi, A

Get full text

Driver mutations’ effect in secondary myelofibrosis: an international multicenter study based on 781 patients by Passamonti, F, Mora, B, Giorgino, T, Guglielmelli, P, Cazzola, M, Maffioli, M, Rambaldi, A, Caramella, M, Komrokji, R, Gotlib, J, Kiladjian, J J, Cervantes, F, Devos, T, Palandri, F, De Stefano, V, Ruggeri, M, Silver, R, Benevolo, G, Albano, F, Caramazza, D, Rumi, E, Merli, M, Pietra, D, Casalone, R, Barbui, T, Pieri, L, Vannucchi, A M

Get full text

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms by Jäger, R, Gisslinger, H, Passamonti, F, Rumi, E, Berg, T, Gisslinger, B, Pietra, D, Harutyunyan, A, Klampfl, T, Olcaydu, D, Cazzola, M, Kralovics, R

“…Transformation to acute leukemia is a major complication of myeloproliferative neoplasms (MPNs), however, the genetic changes leading to transformation remain…”
Get full text

Surface Air‐Pressure Measurements From Space Using Differential Absorption Radar on the Right Wing of the 60 GHz Oxygen Band by Battaglia, A., Rumi, E., Reeves, R., Sikaneta, I., D’Addio, S.

“…Surface air pressure is one of the most important parameters used in Numerical Weather Prediction (NWP) models. Although it has been measured using weather…”
Get full text

Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria by Finazzi, G, Carobbio, A, Thiele, J, Passamonti, F, Rumi, E, Ruggeri, M, Rodeghiero, F, Randi, M L, Bertozzi, I, Vannucchi, A M, Antonioli, E, Gisslinger, H, Buxhofer-Ausch, V, Gangat, N, Rambaldi, A, Tefferi, A, Barbui, T

“…In an international study of 1104 patients with essential thrombocythemia (ET), a histological review according to the 2008 World Health Organization (WHO)…”
Get full text

Clinical relevance of JAK2 (V617F) mutant allele burden by Passamonti, Francesco, Rumi, Elisa

“…Variable proportions of hematopoietic cells that are heterozygous or homozygous for the JAK2 (V617) mutation can be found in patients with myeloproliferative…”
Get full text

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients by Passamonti, Francesco, Rumi, Elisa, Arcaini, Luca, Boveri, Emanuela, Elena, Chiara, Pietra, Daniela, Boggi, Sabrina, Astori, Cesare, Bernasconi, Paolo, Varettoni, Marzia, Brusamolino, Ercole, Pascutto, Cristiana, Lazzarino, Mario

“…1 Division of Hematology and 2 Department of Surgical Pathology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy Correspondence:…”
Get full text

Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders by Passamonti, Francesco, Rumi, Elisa, Pietra, Daniela, Porta, Matteo G. Della, Boveri, Emanuela, Pascutto, Cristiana, Vanelli, Laura, Arcaini, Luca, Burcheri, Sara, Malcovati, Luca, Lazzarino, Mario, Cazzola, Mario

“…We studied the relationship between granulocyte JAK2 (V617F) mutation status, circulating CD34+ cells, and granulocyte activation in myeloproliferative…”
Get full text

Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies by PASSAMONTI, F., RUMI, E., RANDI, M. L., MORRA, E., CAZZOLA, M.

Get full text

P984: MUTATIONAL PATTERNS IN PH‐NEGATIVE MYELOPROLIFERATIVE NEOPLASMS (MPN) by Casetti, I. C., Pietra, D., Ferretti, V. V., De Silvestri, A., Borsani, O., Vanni, D., Trotti, C., Catricalà, S., Favaron, C., Cazzola, M., Arcaini, L., Rumi, E.

Get full text

Allelic imbalance in CALR somatic mutagenesis by Harutyunyan, A S, Jäger, R, Chen, D, Berg, T, Rumi, E, Gisslinger, B, Pietra, D, Gisslinger, H, Cazzola, M, Kralovics, R

Get full text

Increase in leukocyte count over time predicts thrombosis in patients with low‐risk essential thrombocythemia by PASSAMONTI, F., RUMI, E., PASCUTTO, C., CAZZOLA, M., LAZZARINO, M.

Get full text

The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms by OLCAYDU, Damla, RUMI, Elisa, KRALOVICS, Robert, HARUTYUNYAN, Ashot, PASSAMONTI, Francesco, PIETRA, Daniela, PASCUTTO, Cristiana, BERG, Tiina, JÄGER, Roland, HAMMOND, Emma, CAZZOLA, Mario

“…Myeloproliferative neoplasms constitute a group of diverse chronic myeloid malignancies that share pathogenic features such as acquired mutations in the JAK2,…”
Get full text

Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients by Boveri, E., Arcaini, L., Merli, M., Passamonti, F., Rizzi, S., Vanelli, L., Rumi, E., Rattotti, S., Lucioni, M., Picone, C., Castello, A., Pascutto, C., Magrini, U., Lazzarino, M., Paulli, M.

“…Background: Among marginal zone lymphomas (MZLs), bone marrow (BM) involvement features are well established in the splenic marginal zone lymphoma (SMZL); few…”
Get full text